FDA Lays Out Final Guidance for Buprenorphine Pumps, Injections

Drug Industry Daily
A A
Sponsors may not have to conduct new efficacy trials for the anti-opioid treatment buprenorphine injections or implants if there are existing data for similar products under a final guidance issued Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily